{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:52:04Z","timestamp":1786117924660,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni Suef University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) are the most prevalent cutaneous malignancies. C-Kit plays a role in tumor initiation, progress, recurrence, and metastasis. Several medicinal treatments target the c-Kit pathway. The aim of the study was to assess the expression of c-Kit in BCC and cSCC. Furthermore, the study aimed to correlate c-Kit expression with available pathological data of the tumor and clinical data of the patients. A total of 62 excision specimens from patients with BCC (n\u2009=\u2009\n                    <jats:bold>41)<\/jats:bold>\n                    and cSCC (n\u2009=\u2009\n                    <jats:bold>21)<\/jats:bold>\n                    were histopathologically and immunohistochemically evaluated using anti-c-Kit, a rabbit monoclonal antibody clone IHC526. More than half of BCC cases (63.4%) showed positive c-Kit expression. C-Kit expression was significantly correlated with age (p-value\u2009=\u20090.011). The intensity of positive c-Kit staining was statistically related to tumor size (p-value\u2009=\u20090.028). All cSCC cases (100%) showed negative c-Kit expression. Receiver operating characteristic (ROC) curve analysis demonstrated an area under the curve (AUC) of 0.817 (95% confidence interval: 0.714\u20130.920, p-value\u2009&lt;\u20090.001), with a sensitivity of 63.4% and a specificity of 100% in differentiating BCC from cSCC. Assessment of c-Kit expression may be beneficial in the diagnosis of BCC and in distinguishing it from cSCC. Its high specificity supports its diagnostic utility; however, due to its moderate sensitivity, it should be interpreted in conjunction with routine histopathological findings. While this study was a diagnostic, it suggested that c-Kit inhibitors may have therapeutic effects in BCC cases that express c-Kit; however, more research is needed to validate this.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-64048-z","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:27:28Z","timestamp":1786026448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of c-Kit immunohistochemical expression in cutaneous basal and squamous cell carcinomas"],"prefix":"10.1038","volume":"16","author":[{"given":"Doaa Nasr Eldin Sedky","family":"Haroun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Ahmed","family":"Abd Elmaogod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abla Sayed","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"64048_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jdv.17709","volume":"36","author":"C Dessinioti","year":"2022","unstructured":"Dessinioti, C., Pitoulias, M. & Stratigos, A. J. Epidemiology of advanced cutaneous squamous cell carcinoma. J. Eur. Acad. Dermatol. Venereol. 36, 39\u201350 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"64048_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4236\/jct.2019.1010072","volume":"10","author":"IS Fayek","year":"2019","unstructured":"Fayek, I. S., Rifaat, M. A. & Mohammed, D. B. Management and clinicopathologic aspects of non-melanoma skin cancer of the head and neck: A retrospective institutional-based study at the Egyptian National Cancer Institute. J. Cancer Ther. 10, 846\u2013862 (2019).","journal-title":"J. Cancer Ther."},{"key":"64048_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jdv.17969","volume":"36","author":"CSK Fuchs","year":"2022","unstructured":"Fuchs, C. S. K. et al. 2021 international consensus statement on optical coherence tomography for basal cell carcinoma: image characteristics, terminology, and educational needs. J. Eur. Acad. Dermatol. Venereol. 36, 772\u2013778 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"64048_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082956","volume":"21","author":"R Corchado-Cobos","year":"2020","unstructured":"Corchado-Cobos, R., Garc\u00eda-Sancha, N., Gonz\u00e1lez-Sarmiento, R., P\u00e9rez-Losada, J. & Ca\u00f1ueto, J. Cutaneous squamous cell carcinoma: From biology to therapy. Int. J. Mol. Sci. 21, 2956 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"64048_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/biomedicines9020171","volume":"9","author":"L Fania","year":"2021","unstructured":"Fania, L. et al. Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches. Biomedicines 9, 171 (2021).","journal-title":"Biomedicines"},{"key":"64048_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3348\/kjr.2019.0508","volume":"21","author":"M Kawaguchi","year":"2020","unstructured":"Kawaguchi, M. et al. Magnetic resonance imaging findings differentiating cutaneous basal cell carcinoma from squamous cell carcinoma in the head and neck region. Korean J. Radiol. 21, 325\u2013331 (2020).","journal-title":"Korean J. Radiol."},{"key":"64048_CR7","first-page":"683","volume":"22","author":"E Sheikh","year":"2022","unstructured":"Sheikh, E. et al. Role and significance of c-KIT receptor tyrosine kinase in cancer: a review. Bosn J. Basic. Med. Sci. 22, 683\u2013695 (2022).","journal-title":"Bosn J. Basic. Med. Sci."},{"key":"64048_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s12032-012-0444-0","volume":"30","author":"T Terada","year":"2013","unstructured":"Terada, T. Frequency of KIT expression in basal cell carcinomas: an immunohistochemical study on 66 cases. Med. Oncol. 30, 444 (2013).","journal-title":"Med. Oncol."},{"key":"64048_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/cup.12632","volume":"43","author":"K Goto","year":"2016","unstructured":"Goto, K., Kiyono, T., Tsuchida, K. & Uchida, N. Expression of c-KIT in cutaneous squamous cell carcinoma: an immunohistochemical study. J. Cutan. Pathol. 43, 219\u2013226 (2016).","journal-title":"J. Cutan. Pathol."},{"key":"64048_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3934\/molsci.2021.1.1","volume":"8","author":"M Ramezani","year":"2021","unstructured":"Ramezani, M. et al. Evaluation of c-Kit (CD117) expression in patients with squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) of the skin. AIMS Mol. Sci. 8, 1. https:\/\/doi.org\/10.3934\/molsci.2021.1.1 (2021).","journal-title":"AIMS Mol. Sci."},{"key":"64048_CR11","doi-asserted-by":"crossref","unstructured":"Kim, S. W., Roh, J. & Park, C. S. Immunohistochemistry for pathologists: protocols, pitfalls, and tips. J. Pathol. Transl Med. 50, 411\u2013418. https:\/\/doi.org\/10.4132\/jptm.2016.08. (2016).","DOI":"10.4132\/jptm.2016.08.08"},{"key":"64048_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-83328-2","volume-title":"Handbook of practical immunohistochemistry: frequently asked questions","author":"F Lin","year":"2022","unstructured":"Lin, F., Prichard, J. W., Liu, H. & Wilkerson, M. L. Handbook of practical immunohistochemistry: frequently asked questions (Springer Nature, 2022)."},{"key":"64048_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/cup.12632","volume":"43","author":"K Goto","year":"2016","unstructured":"Goto, K. et al. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma. J. Cutan. Pathol. 43, 219\u2013226 (2016).","journal-title":"J. Cutan. Pathol."},{"key":"64048_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/cup.12492","volume":"42","author":"K Goto","year":"2015","unstructured":"Goto, K. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine\/eccrine or sebaceous differentiation from other epithelial tumors of the skin. J. Cutan. Pathol. 42, 480\u2013488 (2015).","journal-title":"J. Cutan. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64048-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64048-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64048-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:47:40Z","timestamp":1786027660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64048-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["64048"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-64048-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24336"}}